- Home
- CPBI vs CVM Comparison
CPBI vs CVM Comparison
Compare CPBI & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- CVM
- Stock Information
- Founded
- CPBI 2023
- CVM 1983
- Country
- CPBI United States
- CVM United States
- Employees
- CPBI N/A
- CVM N/A
- Industry
- CPBI
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPBI
- CVM Health Care
- Exchange
- CPBI Nasdaq
- CVM Nasdaq
- Market Cap
- CPBI 67.1M
- CVM 60.9M
- IPO Year
- CPBI N/A
- CVM 1987
- Fundamental
- Price
- CPBI $16.03
- CVM $8.61
- Analyst Decision
- CPBI
- CVM
- Analyst Count
- CPBI 0
- CVM 0
- Target Price
- CPBI N/A
- CVM N/A
- AVG Volume (30 Days)
- CPBI 6.5K
- CVM 72.3K
- Earning Date
- CPBI 01-01-0001
- CVM 08-14-2025
- Dividend Yield
- CPBI N/A
- CVM N/A
- EPS Growth
- CPBI 0.69
- CVM N/A
- EPS
- CPBI 0.98
- CVM N/A
- Revenue
- CPBI $19,464,000.00
- CVM N/A
- Revenue This Year
- CPBI N/A
- CVM N/A
- Revenue Next Year
- CPBI N/A
- CVM N/A
- P/E Ratio
- CPBI $16.55
- CVM N/A
- Revenue Growth
- CPBI 9.30
- CVM N/A
- 52 Week Low
- CPBI $13.00
- CVM $1.98
- 52 Week High
- CPBI $16.71
- CVM $32.70
- Technical
- Relative Strength Index (RSI)
- CPBI 51.15
- CVM 42.29
- Support Level
- CPBI $15.96
- CVM $8.50
- Resistance Level
- CPBI $16.27
- CVM $9.35
- Average True Range (ATR)
- CPBI 0.08
- CVM 0.63
- MACD
- CPBI -0.05
- CVM -0.13
- Stochastic Oscillator
- CPBI 27.27
- CVM 20.54
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.